Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Cholestin Drug Determination Remanded For Utah Court Review

This article was originally published in The Tan Sheet

Executive Summary

A Utah federal judge must decide if FDA was arbitrary and capricious in determining Pharmanex' Cholestin red yeast rice supplement constitutes a drug, a Denver federal appeals court states in a July 21 opinion.
Advertisement

Related Content

Cholestin Red Yeast Rice Shipments Halted Pending FDA Talks
Cholestin Red Yeast Rice Shipments Halted Pending FDA Talks
Cholestin Red Yeast Rice Shipments Halted Pending FDA Talks
Mevacor Study Comparing Rx, OTC Use Is Among FDA Panel Suggestions
FDA Dietary Supplement Definition In Cholestin Case Set Aside By Court
FDA Dietary Supplement Definition In Cholestin Case Set Aside By Court

Topics

Advertisement
UsernamePublicRestriction

Register

PS091484

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel